Physiological role of ROCKs in the cardiovascular system
K Noma, N Oyama, JK Liao - American Journal of …, 2006 - journals.physiology.org
Rho-associated kinases (ROCKs), the immediate downstream targets of RhoA, are
ubiquitously expressed serine-threonine protein kinases that are involved in diverse cellular …
ubiquitously expressed serine-threonine protein kinases that are involved in diverse cellular …
Rho kinase (ROCK) inhibitors
JK Liao, M Seto, K Noma - Journal of cardiovascular …, 2007 - journals.lww.com
The Rho kinase (ROCK) isoforms, ROCK1 and ROCK2, were initially discovered as
downstream targets of the small GTP-binding protein Rho. Because ROCKs mediate various …
downstream targets of the small GTP-binding protein Rho. Because ROCKs mediate various …
The function of Rho-associated kinases ROCK1 and ROCK2 in the pathogenesis of cardiovascular disease
S Hartmann, AJ Ridley, S Lutz - Frontiers in pharmacology, 2015 - frontiersin.org
Rho-associated kinases ROCK1 and ROCK2 are serine/threonine kinases that are
downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in …
downstream targets of the small GTPases RhoA, RhoB, and RhoC. ROCKs are involved in …
Rho kinases in cardiovascular physiology and pathophysiology
Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein
RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have …
RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have …
Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease
Q Zhou, C Gensch, JK Liao - Trends in pharmacological sciences, 2011 - cell.com
ROCKs are important regulators of the actin cytoskeleton. Because changes in the actin
cytoskeleton underlie vascular contractility and remodeling, inflammatory cell recruitment …
cytoskeleton underlie vascular contractility and remodeling, inflammatory cell recruitment …
Rho kinase as a therapeutic target in cardiovascular disease
Rho kinase (ROCK) belongs to the AGC (PKA/PKG/PKC) family of serine/threonine kinases
and is a major downstream effector of the small GTPase RhoA. ROCK plays central roles in …
and is a major downstream effector of the small GTPase RhoA. ROCK plays central roles in …
Rho kinase: an important mediator of atherosclerosis and vascular disease
Q Zhou, JK Liao - Current pharmaceutical design, 2009 - ingentaconnect.com
Atherosclerosis is a complex inflammatory process characterized by the cross-talk between
excessive inflammation and lipid accumulation. In the past few years, compelling evidence …
excessive inflammation and lipid accumulation. In the past few years, compelling evidence …
Development of Rho-kinase inhibitors for cardiovascular medicine
H Shimokawa, M Rashid - Trends in pharmacological sciences, 2007 - cell.com
Rho-kinase (ROCK) is one of the downstream effectors of the small G-protein Rho. The Rho–
ROCK pathway has an important role in mediating various cellular functions, including …
ROCK pathway has an important role in mediating various cellular functions, including …
Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis
Abstract Significance: The 3-hydroxy-methylglutaryl coenzyme A reductase inhibitors or
statins are important therapeutic agents for lowering serum cholesterol levels. However …
statins are important therapeutic agents for lowering serum cholesterol levels. However …
Rho kinase as potential therapeutic target for cardiovascular diseases: opportunities and challenges
E Hu, D Lee - Expert Opinion on Therapeutic Targets, 2005 - Taylor & Francis
Rho kinase (ROCK) belongs to a family of Ser/Thr protein kinases that are activated via
interaction with the small GTP-binding protein RhoA. Growing evidence suggests that RhoA …
interaction with the small GTP-binding protein RhoA. Growing evidence suggests that RhoA …